Exclusive

Publication

Byline

Location

Brothers Osborne Reimagine Tom Petty's 'Runnin' Down A Dream' For Bobby Rahal Documentary

India, June 27 -- Big Machine Racing Productions recently released Tom Petty's "Runnin' Down A Dream" performed by Brothers Osborne for a Bobby Rahal documentary. Bobby Rahal: True American Racer (In... Read More


Don Toliver Announces UK Tour Dates For November

India, June 27 -- Rapper and singer Don Toliver has announced U.K. tour dates scheduled for November this year. Toliver comes to the U.K. this winter, closing out a major European tour with shows in ... Read More


FDA Declines To Approve Sobi's NASP To ?treat Uncontrolled Gout

India, June 27 -- Swedish Orphan Biovitrum AB (SWOBY) on Friday announced that the U.S. Food and Drug Administration has issued a Complete Response Letter (CRL) for the Biologics License Application (... Read More


Tim McGraw Announces Limited Engagement At The Colosseum At Caesars Palace In Las Vegas

India, June 27 -- Country superstar Tim McGraw has announced a five-night limited engagement at the Colosseum at Caesars Palace in Las Vegas. McGraw will return to The Colosseum this fall, with the s... Read More


How Much Homework Is Too Much? New Study Has The Answer

India, June 26 -- A major new study published in the Journal of Affective Disorders finds that homework can support learning - but only up to a very clear limit. Beyond that point, it begins to harm s... Read More


Larimar To Host Investor Event On Nomlabofusp Program On Monday, Stock Up

India, June 26 -- Larimar Therapeutics, Inc. (LRMR), a clinical-stage biotechnology company focused on rare diseases, announced it will host an investor event to provide updates on its Nomlabofusp pro... Read More


FDA To Review Replimmune's Third BLA Submission For RP1 In Advanced Melanoma; Response By Aug 2026

India, June 26 -- Replimmune Group Inc. (REPL), a clinical-stage biotechnology company, on Friday announced the FDA acceptance of the biological license application (BLA) for RP-1 in combination with ... Read More


Lupin Gets Tentative FDA Nod For Enzalutamide Tablets

India, June 26 -- Lupin Limited (LUPIN) has received tentative approval from the U.S. FDA for its generic Enzalutamide Tablets, marking another step in the company's effort to expand its oncology port... Read More


Viridian Wins FDA Approval For Lumvoa In Thyroid Eye Disease; Stock Up

India, June 26 -- Viridian Therapeutics, Inc. (VRDN) announced that the U.S. FDA has approved Lumvoa for the treatment of thyroid eye disease, marking the company's first commercial product and a majo... Read More


Medicenna Therapeutics FY26 Loss Widens

India, June 26 -- Medicenna Therapeutics Corp. (MDNAF) reported a wider loss for the financial year ended March 31, 2026, and provided updates on its anticipated clinical milestones. Company Profile ... Read More